Evidence map›Paper›PMID 41185853›Full record

ArticleBioinformatics advances2025

Benchmarking of variant pathogenicity prediction methods using a population genetics approach.

Mikhail Gudkov, Loïc Thibaut, Steven Monger, Debjani Das, David S Winlaw, Sally L Dunwoodie, Eleni Giannoulatou, Congenital Heart Disease Synergy Study Group

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mikhail GudkovVictor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.
Loïc ThibautInstitute for Molecular Bioscience, University of Queensland, St Lucia, QLD 4072, Australia.
Steven MongerSchool of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, Darlinghurst, NSW 2010, Australia.
Debjani DasVictor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.
David S WinlawAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611,  United States.
Sally L DunwoodieVictor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.ORCID https://orcid.org/0000-0002-2069-7349
Eleni GiannoulatouVictor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.ORCID https://orcid.org/0000-0002-7084-6736
Congenital Heart Disease Synergy Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Variant pathogenicity predictors are essential for identifying new associations between genetic variants and rare diseases. However, despite the availability of numerous predictors, there is no clear consensus on which methods provide the most reliable results. The common practice of training, testing, and benchmarking these predictors using known variant sets from disease or mutagenesis studies raises concerns about ascertainment bias and data circularity. Results: We benchmarked commonly used pathogenicity predictors using an orthogonal approach that does not rely on predefined "ground truth" datasets. By leveraging population-level genomic data from gnomAD and the Context-Adjusted Proportion of Singletons (CAPS) metric, we identified CADD and REVEL as the best-performing predictors for distinguishing extremely deleterious variants from moderately deleterious ones. REVEL demonstrated superior calibration. Additionally, we show that CAPS can serve as a meta-analysis tool for interpreting variant annotations and highlight biases in ClinVar-based predictor training. Availability and implementation: CAPS analysis and benchmarking results are available at https://github.com/mgudVCCRI/PopGenVariantFiltering.

Identifiers

PMID41185853
PMCPMC12579982

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.